Name
Docline OÜ
Registry code
12197114
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.11.2011 (13)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86211 - Provision of general medical treatment
458 113 €
402 663 €
88%
261 €
(estimate is approximate)
943 769 €
3
Submitted
No tax arrears
43%
42%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Eero Merilind 20.04.1971 (53) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2019 18.10.2020 | 2020 25.06.2021 | 2021 15.06.2022 | 2022 12.06.2023 | 2023 08.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 94 741 € | 198 708 € | 193 629 € | 56 002 € | 458 113 € |
| Net profit (loss) for the period | 61 999 € | 174 518 € | 197 830 € | -48 413 € | 402 663 € |
| Profit Margin | 65% | 88% | 102% | -86% | 88% |
| Current Assets | 230 002 € | 404 520 € | 606 791 € | 542 554 € | 959 401 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 230 002 € | 404 520 € | 606 791 € | 542 554 € | 959 401 € |
| Current Liabilities | 304 € | 304 € | 17 274 € | 1 449 € | 15 632 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 229 698 € | 404 216 € | 589 517 € | 541 105 € | 943 769 € |
| Employees | 2 | 2 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 120 € | 3 799.48 € | 3 338.06 € | 2 |
| 2023 Q4 | - | 1 298.56 € | 1 392.05 € | 3 |
| 2023 Q3 | - | 566.64 € | 598.53 € | 3 |
| 2023 Q2 | 458.3 € | - | 598.53 € | 3 |
| 2023 Q1 | - | 566.64 € | 598.53 € | 3 |
| 2022 Q4 | 1 500 € | 514.36 € | 541.85 € | 3 |
| 2022 Q3 | 445.5 € | 640.08 € | 598.53 € | 3 |
| 2022 Q2 | 370 € | 644.75 € | 598.53 € | 3 |
| 2022 Q1 | 1 789.25 € | 3 311.94 € | 1 009.65 € | 3 |
| 2021 Q4 | 928 € | 489.56 € | 462.39 € | 3 |
| 2021 Q3 | 19 212.34 € | 438.3 € | 468.6 € | 3 |
| 2021 Q2 | 23 697.02 € | 1 167.2 € | 808.68 € | 3 |
| 2021 Q1 | 20 672.78 € | - | 695.32 € | 3 |
| 2020 Q4 | 41 547 € | 281.46 € | 298.56 € | 3 |
| 2020 Q3 | 47 887.32 € | - | 298.56 € | 3 |
| 2020 Q2 | 25 767.04 € | - | 298.56 € | 3 |
| 2020 Q1 | 47 704.15 € | 281.46 € | 298.56 € | 3 |
